# Bowman-Birk Inhibitor Concentrate in Healthy Men

> **NCT00679094** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 20 (actual)

## Conditions studied

- Healthy, no Evidence of Disease

## Interventions

- **DRUG:** Bowman-Birk inhibitor concentrate
- **OTHER:** placebo
- **OTHER:** pharmacological study
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00679094
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2016-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00679094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00679094, "Bowman-Birk Inhibitor Concentrate in Healthy Men". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00679094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*